There is far too much incrementalism in the present research and development of therapies to treat aging. Much of the field is engaged in mimicking calorie restriction or repurposing existing drugs that were found to increase mouse life span by a few percentage points. This will not meaningfully change the shape...
Read Full StoryTop News
Related
Question from your neighbor: “Can anyone recommend a good landlord/tenant lawyer? For many...”
, 1d
0
Van ECK Associates Corp Purchases 18,080 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)
, 3min
0